[link removed] [link removed] [link removed] [link removed] [link removed]

Email not displaying correctly? View it in your browser. ([link removed])

[link removed]
Issue 1,766: July 17, 2024
Top Stories
* Immunize​.org updates its "Record of Vaccine Declination" (#IZX1)
* Explore CDC’s interactive online training, “Fostering a Culture of Immunization in Your Practice”; CE credit available (#IZX2)
* CDC offers educational activity through Medscape on ACIP recommendations for tick-borne encephalitis vaccine; CE and CME credit available (#IZX3)
* Vaccinate Your Family launches back-to-school immunization awareness campaign; spread the word using their FirstDayVax toolkit in English and Spanish (#IZX4)
* “Why are American Indian and Alaska Native children recommended to receive RSV preventive antibody for their second RSV season?” Watch the 1-minute answer, part of the  Ask the Experts Video Series on YouTube.  (#IZX5)
* Vaccines in the news (#IZX6)


Immunize​.org Website and Clinical Resources
* Spotlight on the website: Vaccine History Timeline (#IZX7)


Featured Resources
* The Public Health Foundation and CDC post a toolkit for education professionals on how schools can support vaccination catch-up (#IZX8)
* North Dakota State University Center for Immunization Research and Education offers free training module to boost clinicians’ confidence in addressing vaccine hesitancy; CME credit available (#IZX9)


Notable Publications
* “Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes” published in JAMA (#IZX10)


Global News
* "The Vaccine Back-Stop," published by Gavi, The Vaccine Alliance (#IZX11)

Upcoming Events
* In-person: Registration open for CDC’s 49th National Immunization Conference on August 12–14 in Atlanta; CE credit offered (#IZX12)



Editorial Information (#Editorial)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
Immunize​.org updates its "Record of Vaccine Declination"

Immunize​.org recently updated its Record of Vaccine Declination ([link removed]) , a form that any vaccination provider may use to document parents’ refusal of vaccination. The record also documents that parents have been provided clear information concerning the potential consequences of their choices.

The form now incorporates RSV preventive antibody in the table of immunizing products that parents could decline. The reverse side of the record gives healthcare professionals using the form additional information about the value of documenting declination in the medical record, along with useful references. This section was updated to provide more recent examples of the consequences of not vaccinating, as well as links to additional in-depth resources from AAP and other organizations.

[link removed]

Related Links
* Immunize​.org: Clinical Resources: Documenting Vaccination ([link removed]) main page
* Immunize​.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria

Back to top (#Top)

------------------------------------------------------------
Explore CDC’s interactive online training, “Fostering a Culture of Immunization in Your Practice”; CE credit available

Vaccination is a team effort. From the office vaccine champion to the staff at the front desk, everyone has an important role to play in setting patient expectations and supporting a positive vaccination experience. CDC offers Fostering a Culture of Immunization in Your Practice ([link removed]) , a free online training course that provides healthcare professionals with practical strategies and resources to help create a positive culture of immunization in their clinics, ensuring the best possible care for patients and promoting vaccination efforts.

The course offers CE credit.

View the course ([link removed]) .
Back to top (#Top)

------------------------------------------------------------
CDC offers educational activity through Medscape on ACIP recommendations for tick-borne encephalitis vaccine; CE and CME credit available

Tick-borne encephalitis (TBE) affects people bitten by ticks in parts of Europe and Asia. In 2023, a licensed TBE vaccine was recommended for use in the United States in travelers who anticipate being at risk for TBE exposure. CDC, through Medscape, offers an online resource titled Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023 ([link removed]) . The activity will help participants to understand the epidemiology and virology of TBE, evaluate the clinical presentation and laboratory diagnosis of patients with suspected TBE, assess the safety and immunogenicity of the TBE vaccine, and distinguish appropriate candidates for TBE vaccination.

CE credits are available for physicians, nurses, and pharmacists.

[link removed]

View the activity ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Vaccinate Your Family launches back-to-school immunization awareness campaign; spread the word using their FirstDayVax toolkit in English and Spanish

Vaccinate Your Family (VYF) launched its #FirstDayVax Back to School campaign ([link removed]) to promote the importance of back-to-school immunizations. For students from elementary school to college, vaccinations are a critical step in keeping students, schools, and communities healthy. Find the sharable assets in the #FirstDayVax Toolkit ([link removed]) , also available in Spanish ([link removed]) .

[link removed]

Use the
#FirstDayVax hashtag on social media and tag @vaccinateyourfamily (@vaxyourfam on X) so VYF can amplify your posts.
Back to top (#Top)
------------------------------------------------------------
“Why are American Indian and Alaska Native children recommended to receive RSV preventive antibody for their second RSV season?” Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube. 

This week, our featured episode from the Ask the Experts Video Series is Why are American Indian and Alaska Native children recommended to receive RSV preventive antibody for their second RSV season? ([link removed]  ) This video briefly highlights two key reasons ACIP recommends nirsevimab (Beyfortus, Sanofi) for American Indian or Alaska Native (AI/AN) children entering their second RSV season:
* Recent studies showing a significantly higher incidence of hospitalization due to RSV among AI/AN children in their second year of life compared to other children of similar age
* Transportation and medical care challenges for AI/AN children who live in small or remote communities and develop serious RSV disease

The 1-minute video is available on our YouTube channel ([link removed]) , along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.

[link removed]

Like, follow, and share Immunize​.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])

Related Links
* Immunize​.org: Ask the Experts: Respiratory syncytial virus (RSV) ([link removed]) main page
* Immunize​.org: Vaccines A–Z: RSV (Respiratory Syncytial Virus) ([link removed]) main page

Back to top (#Top)
------------------------------------------------------------
Vaccines in the news

These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* Nature: Vaccines Save Lives: How Can Uptake Be Increased? ([link removed]) (Commentary) (7/9/24)
* Washington Post: What It’s Like to Survive Measles ([link removed]) (7/7/24)

Back to top (#Top)
------------------------------------------------------------
Immunize​.org Website and Clinical Resources
------------------------------------------------------------
Spotlight on the website: Vaccine History Timeline

Immunize​.org's Vaccine History Timeline ([link removed]) offers a simple and handy chronology of events related to vaccine-preventable diseases (VPDs) and advances in vaccinology, beginning with Hippocrates’ description of diseases now preventable by vaccines in 400 B.C.E. and continuing up to June 28, 2024, when the most recent ACIP recommendations were accepted by the director of CDC. To access it, go to the "Vaccines & VIS" menu tab and click on the “Vaccine History Timeline.”

Use the vertical scroll bar or click on a year to move back in time to explore vaccine history. On the right, click on “Back to Top” to jump back up to the most recent year.

“The Vaccine History Timeline” web page includes useful related resources, such as links to vaccine history resources from the College of Physicians of Philadelphia and the National Library of Medicine.

Back to top (#Top)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
The Public Health Foundation and CDC post a toolkit for education professionals on how schools can support vaccination catch-up

The Public Health Foundation, in collaboration with CDC, now offers a toolkit for education professionals ([link removed]) to support routine vaccination catch-up. This is part of a series of toolkits being developed for CDC's broader Let's RISE ([link removed]) (Routine Immunizations on Schedule for Everyone) campaign. This toolkit is designed for superintendents, school administrators, school nurses, and all school health staff. It contains evidence-based strategies, tools, and resources from a wide range of partners.

[link removed]

View the toolkit ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
North Dakota State University Center for Immunization Research and Education offers free training module to boost clinicians’ confidence in addressing vaccine hesitancy; CME credit available

North Dakota State University Center for Immunization Research and Education (CIRE) created a free, four-part online video training module, Motivational Interviewing for Vaccine Hesitancy ([link removed]) , which is designed to boost clinicians’ confidence in addressing vaccine hesitancy in medical encounters. Viewers will be introduced to several communication strategies rooted in motivational interviewing and will develop the ability to confidently address and resolve patient concerns regarding vaccinations through effective communication and evidence-based information.

[link removed]

Following the training, participants are eligible for CME credit.

View the training module ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes” published in JAMA

In its July 8 issue, JAMA published Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes ([link removed]) . This safety study showed no evidence of an increased risk of preterm birth (PTB) or certain related outcomes following vaccination with Abrysvo (Pfizer) RSV vaccine during pregnancy.

This retrospective study was conducted at two New York City hospitals within a single healthcare system. Subjects were patients who gave birth to singleton children at 32 weeks’ gestation or later, from September 2023 through January 2024. Prenatal RSV vaccination with Abrysvo was collected from the health system’s electronic health records. The researchers assessed PTB, defined as less than 37 weeks’ gestation, hypertensive disorders of pregnancy (HDP), and small-for-gestational age (SGA) birth weight, among other outcomes. The authors concluded:

In this cohort study of pregnant individuals who delivered at 32 weeks’ gestation or later, the RSVpreF vaccine was not associated with an increased risk of PTB and perinatal outcomes. These data support the safety of prenatal RSVpreF vaccination, but further investigation into the risk of HDP is warranted.
Back to top (#Top)
------------------------------------------------------------
Global News
------------------------------------------------------------
"The Vaccine Back-Stop," published by Gavi, The Vaccine Alliance

On July 9, Gavi published The Vaccine Back-Stop ([link removed]) , which highlights the importance in all countries of checking the vaccination status of children when visiting health facilities to help those who missed vaccinations. Catching children up on vaccines is an important responsibility of primary healthcare systems. Any visit to a health facility is an opportunity to ask about vaccination status and a chance for providers to administer vaccines.

[link removed]

Related Link
* WHO: Global partners announce a new effort—“The Big Catch-up”—to vaccinate millions of children and restore immunization progress lost during the pandemic ([link removed]) (4/24/23)

Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
In-person: Registration open for CDC’s 49th National Immunization Conference on August 12–14 in Atlanta; CE credit offered

CDC will host National Immunization Conference 2024 ([link removed]) on August 12–14 in Atlanta, GA. The Agenda at a Glance ([link removed]) is now available. Program content will cover science, policy, education, and implementation issues related to immunization and vaccine-preventable diseases.

Register for the conference ([link removed]) now. The general attendee fee is $685. CE will be offered.

If you attend, be sure and find the team at Immunize​.org's exhibit booth and say hello!

[link removed]

See CDC's National Immunization Conference 2024 ([link removed]) website for more information.
Back to top (#Top)

------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde

About IZ Express
Immunize​.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize​.org is the source of the material and provide a link to this issue ([link removed]) .

IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize​.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer ([link removed])
ISSN: 2771-8085

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA